Why not Generex owns the IP and new formulation - unfortunately in Pharma a blown asset is a blown asset, and OL is a blown asset, phase 1, 2, 3 all have to be redone, the amount of money that will take on a blown asset would never allow for new value, and a lot of apprehension in the market, we’ve talked about this when I first took over all public info and common sense as it relates to pharma public companies, once we have our own free cash flows as I’ve stated we will get back to this, the new formulation as I’ve said is a winner.